PHS
VERV
PFM Health Sciences’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-155,495
| Closed | -$711K | – | 75 |
|
|
2025
Q1 | $711K | Buy |
155,495
+29,496
| +23% | +$135K | 0.05% | 59 |
|
|
2024
Q4 | $711K | Hold |
125,999
| – | – | 0.04% | 70 |
|
|
2024
Q3 | $610K | Buy |
+125,999
| New | +$610K | 0.03% | 72 |
|
|
2023
Q3 | – | Sell |
-186,087
| Closed | -$3.49M | – | 81 |
|
|
2023
Q2 | $3.49M | Hold |
186,087
| – | – | 0.14% | 70 |
|
|
2023
Q1 | $2.68M | Sell |
186,087
-31,215
| -14% | -$450K | 0.12% | 65 |
|
|
2022
Q4 | $4.2M | Sell |
217,302
-951,506
| -81% | -$18.4M | 0.15% | 63 |
|
|
2022
Q3 | $40.1M | Buy |
1,168,808
+323,622
| +38% | +$11.1M | 1.45% | 27 |
|
|
2022
Q2 | $12.9M | Buy |
845,186
+475,421
| +129% | +$7.26M | 0.49% | 52 |
|
|
2022
Q1 | $8.44M | Buy |
+369,765
| New | +$8.44M | 0.32% | 56 |
|